Back
Cartesian Therapeutics Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Sell
37
RNAC
Cartesian Therapeutics
Last Price:
16.33
Seasonality Move:
-14.99%
Buy
65
REGN
Regeneron Pharmaceuticals
Last Price:
1,155.14
Seasonality Move:
5.53%
Sell
37
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy, Sell or Hold?
- The current Cartesian Therapeutics [RNAC] share price is $16.75. The Score for RNAC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
- The current Regeneron Pharmaceuticals [REGN] share price is $1,153.35. The Score for REGN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- REGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RNAC Stock Price Chart
What is Cartesian Therapeutics's stock price today?
-
The Cartesian Therapeutics share price today is $16.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNAC is experiencing buying pressure, which is a positive indicator for future bullish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $1,153.35
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
RNAC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 60.37 | Buy |
Chaikin Money Flow: | 26939 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.19 - 15.15) | Buy |
Bollinger Bands (100): | (14.16 - 27.02) | Sell |
REGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.58 | Buy |
Relative Strength Index (14 RSI): | 51.12 | Buy |
Chaikin Money Flow: | -223087 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1144.52 - 1193.12) | Sell |
Bollinger Bands (100): | (971.06 - 1138.5) | Buy |
RNAC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.63 | Buy |
20-day SMA: | 14.35 | Buy |
50-day SMA: | 15.28 | Buy |
200-day SMA: | 20.86 | Sell |
8-day EMA: | 15.15 | Buy |
20-day EMA: | 14.69 | Buy |
50-day EMA: | 16.18 | Buy |
200-day EMA: | 21.88 | Sell |
REGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1150.29 | Buy |
20-day SMA: | 1173.88 | Sell |
50-day SMA: | 1121.23 | Buy |
200-day SMA: | 988.59 | Buy |
8-day EMA: | 1154.71 | Sell |
20-day EMA: | 1155.88 | Sell |
50-day EMA: | 1123.51 | Buy |
200-day EMA: | 1002.89 | Buy |
Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $2.16 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.99 per share, an increase next quarter of $1.60 per share, an increase this year of $2.56 per share, and an increase next year of $3.90 per share.
Cartesian Therapeutics Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regeneron Pharmaceuticals Technical Analysis
Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |